Kheirallah, Samar <br/><br/>
Rituximab inhibits B-cell receptor signaling.  [electronic resource] 

 -  Blood  Feb 2010 
 - 985-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2009-08-237537  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Murine-Derived<br/>Blotting, Western<br/>Calcium--metabolism<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Cholesterol--metabolism<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Flow Cytometry<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--metabolism<br/>Membrane Microdomains--drug effects<br/>Phospholipase C gamma--metabolism<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 6--genetics<br/>Protein-Tyrosine Kinases--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>RNA Interference<br/>Receptors, Antigen, B-Cell--metabolism<br/>Rituximab<br/>Signal Transduction--drug effects<br/>Syk Kinase<br/>Time Factors<br/>src-Family Kinases--metabolism